谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Randomized Phase 2 Study of Neratinib with or Without Fulvestrant for Patients with HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer.

Stefania Morganti, Xiangying Chu,Tarah J Ballinger, Nisha Unni, Sarah Sinclair,Robert Wesolowski, Alyssa M Pereslete, Paulina Lange,Nabihah Tayob,Nancy U Lin, Jose P Leone, Ian E Krop,Sara M Tolaney,Heather A Parsons

Clinical breast cancer（2025）

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要